Lexeo Therapeutics, Inc. (LXEO)

NASDAQ: LXEO · Real-Time Price · USD

7.23

-0.03 (-0.41%)

At close: Jan 21, 2026, 4:00 PM EST

7.27

+0.04 (0.55%)

After-hours: Jan 21, 2026, 7:19 PM EST

Lexeo Therapeutics Employees

Lexeo Therapeutics had 72 employees as of December 31, 2024. The number of employees increased by 14 or 24.14% compared to the previous year.

Employees

72

Change (1Y)

14

Growth (1Y)

24.14%

Revenue / Employee

n/a

Profits / Employee

-$1,457,861

Market Cap

527.70M

Employees Chart

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2024	72	14	24.14%
Dec 31, 2023	58	34	141.67%
Dec 31, 2021	24	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

LXEO News

7 days ago - Lexeo Therapeutics, Inc. (LXEO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
9 days ago - Lexeo Therapeutics, Inc. (LXEO) Discusses Preliminary Data From Phase I/II Trial of LX2020 for PKP2-Associated Arrhythmogenic Cardiomyopathy Transcript - Seeking Alpha
9 days ago - Lexeo Therapeutics Announces Positive Interim Phase I/II Data for LX2020 for the Treatment of PKP2-Associated Arrhythmogenic Cardiomyopathy - GlobeNewsWire
4 weeks ago - Lexeo Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
6 weeks ago - Lexeo Therapeutics, Inc. (LXEO) Clinician Perspectives on Holistic Management of PKP2-Associated Arrhythmogenic Cardiomyopathy Transcript - Seeking Alpha
6 weeks ago - Lexeo Therapeutics to Host Virtual Key Opinion Leader Event at the 22nd Global Cardiovascular Clinical Trialists (CVCT) Forum - GlobeNewsWire
2 months ago - Lexeo Therapeutics: Behind The Rebound - Seeking Alpha
2 months ago - Lexeo Therapeutics Reports Third Quarter 2025 Financial Results and Operational Highlights - GlobeNewsWire